Institutional Cluster

AXGN

Axogen, Inc.
MIXED
Impact 5/10
Horizonweeks Processed1mo ago
Institutional cluster: 6 buyers, 4 sellers (mixed)
Actionable Insight ◆ Mixed

The strong buying by active managers Artemis and Nuveen signals conviction in Axogen's growth story post-earnings, but Wasatch's trimming and the absence of insider buying warrant caution. Monitor next quarter's 13F for whether these positions were held or sold, and watch for any insider open-market purchases to confirm the thesis.

DirectionMixed
Confidencemedium
Horizonweeks
Latest settled — T+20d ⚠ clustered
AXGN ▼ -15.74% at T+20d
NEUTRAL call ✗ call lost -15.74% · α vs SPY -13.85% · entry $49.67 → $41.85
Next anchor: T+60d in 5w
Latest observation: T+33 -14.61% FF3 residual α
Entry anchored
Aug 11, 2026
via day open
T+1d
-3.26%
call -3.26% · α -3.96%
$48.05
settled 7w ago
T+5d
-1.49%
call -1.49% · α -1.05%
$48.93
settled 6w ago
T+20d
-15.74%
call -15.74% · α -13.85%
$41.85
settled 23d ago
T+60d
—
call — · α —
—
in 5w

Executive Summary

A mixed institutional cluster in AXGN for Q2 2026 shows six buyers accumulating $87.1M in new positions, led by Artemis Investment Management (doubled to $64.5M) and Nuveen (doubled to $25.2M), while four sellers trimmed $2.9M, led by Wasatch Advisors trimming 30% of its stake. The buying cluster aligns with the company's strong Q2 earnings beat and raised guidance filed 14 days prior, but the lack of insider buying and the presence of a large seller (Wasatch) tempers conviction. The cluster is dominated by active asset managers, suggesting a shared thesis around accelerating Breast segment growth and expanding insurance coverage, but the 45-day reporting lag means positions may have already been adjusted.

Key Financial Metrics

Direction
accumulating
Buy Value
$107.7M
Sell Value
$2.9M
Net Flow
$84.2M

Institutional Positions

Net institutional flow: $84.2M

▲ Buyers (6)

InstitutionActionChangePosition ValueValue Δ
Artemis Investment ManagementDOUBLED+299.2%$64.5M$52.9M
NuveenDOUBLED+401.1%$25.2M$21.6M
Russell Investments GroupDOUBLED+261.5%$5.9M$4.7M
CitigroupDOUBLED+621.3%$4.2M$3.8M
Victory Capital ManagementADD+45%$7.1M$3.6M
Envestnet Asset ManagementADD+86.7%$844.0K$520.0K

▼ Sellers (4)

InstitutionActionChangePrev ValueValue Δ
Wasatch AdvisorsTRIM-30.2%$61.5M-$1.7M
Panagora Asset ManagementTRIM-57.2%$2.5M-$987.5K
Mml Investors ServicesTRIM-68.1%$458.0K-$254.6K
Exchange Traded ConceptsTRIM-29.4%$1.2M-$19.4K

Key Facts

  • 6 institutional buyers added $87.1M in net new AXGN positions in Q2 2026
  • Artemis Investment Management doubled its stake from $11.6M to $64.5M (+299% shares)
  • Nuveen more than quadrupled its position from $3.6M to $25.2M (+401% shares)
  • Wasatch Advisors trimmed 30% of its stake, reducing from $61.5M to $59.9M
  • Q2 2026 revenue of $69.7M (+23% YoY) beat consensus of $67.1M; full-year guidance raised to at least $279M
  • No open-market insider buying was detected in the window, weakening the signal

Financial Impact

6 institutional buyers accumulated $87.1M in new positions while 4 sellers reduced holdings by $2.9M, for net institutional buying of approximately $84.2M

institutional ownershipfloat

Risk Factors

  • 13F data is 45 days stale; positions may have been unwound since quarter-end
  • Wasatch Advisors, a top-3 holder, trimmed 30% of its stake — a potential red flag
  • No insider buying to corroborate the institutional cluster
  • GAAP net loss widened to -$0.03/share vs +$0.01 a year ago; adjusted EBITDA margin compressed to 12.1% from 16.3%

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-AXGN-2026-Q2
11 reports for AXGN
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+20▲ +24.68%Jul 29, 2026
Filters
Rows
Reports for AXGN — sortable, filterable
TypeNow
Sep 10, 2026
21d ago
424B5
MIXED ★ 6/10
$42.16 $44.23▲ +4.91%▲ +5.13%—
Sep 10, 2026
22d ago
8-K
BULLISH ★ 7/10
$41.85 $45.29▲ +8.21%▲ +8.71%—
Sep 10, 2026
22d ago
Press Release
BEARISH ★ 6/10
$41.85 $45.29▼ −8.21%▼ −8.71%—
Sep 10, 2026
22d ago
Press Release
BULLISH ★ 7/10
$41.85 $45.29▲ +8.21%▲ +8.71%—
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$49.67 $48.93▼ −1.49%▼ −1.05%—
Aug 11, 2026
7w ago
Institutional Cluster
MIXED ★ 5/10
$49.67 $48.93▼ −1.49%▼ −1.05%—
Jul 29, 2026
9w ago
8-K
BULLISH ★ 6/10
$41.37 $45.22▲ +9.31%▲ +3.78%—
Jul 15, 2026
11w ago
Press Release
NEUTRAL ★ 2/10
$38.72 $39.37▲ +1.68%▲ +2.66%—
Jul 9, 2026
12w ago
Institutional Cluster
MIXED ★ 5/10
$43.62 $39.78▼ −8.81%▼ −8.68%—
Jun 12, 2026
16w ago
Institutional Cluster
MIXED ★ 4/10
$43.00 $44.84▲ +4.28%▲ +3.61%—
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (65h 8m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 11, 2026